Literature DB >> 17940807

Diabetic nephropathy in children and adolescents.

Radovan Bogdanović1.   

Abstract

Type 1 diabetes mellitus (T1DM) commonly occurs in childhood or adolescence, although the rising prevalence of type 2 diabetes mellitus (T2DM) in these age groups is now being seen worldwide. Diabetic nephropathy (DN) develops in 15-20% of subjects with T1DM and in similar or higher percentage of T2DM patients, causing increased morbidity and premature mortality. Although overt DN or kidney failure caused by either type of diabetes are very uncommon during childhood or adolescence, diabetic kidney disease in susceptible patients almost certainly begins soon after disease onset and may accelerate during adolescence, leading to microalbuminuria or incipient DN. Therefore, all diabetics warrant ongoing assessment of kidney function and screening for the earliest manifestations of renal injury. Pediatric health care professionals ought to understand about risk factors, strategy for prevention, method for screening, and treatment of early DN. This review considers each form of diabetes separately, including natural history, risk factors for development, screening for early manifestations, and strategy recommended for prevention and treatment of DN in children and adolescents.

Entities:  

Mesh:

Year:  2007        PMID: 17940807     DOI: 10.1007/s00467-007-0583-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  243 in total

1.  Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.

Authors:  E R Mathiesen; E Hommel; H P Hansen; U M Smidt; H H Parving
Journal:  BMJ       Date:  1999-07-03

2.  Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.

Authors:  S Rudberg; R Osterby; H J Bangstad; G Dahlquist; B Persson
Journal:  Diabetologia       Date:  1999-05       Impact factor: 10.122

Review 3.  Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

Authors:  Martin MacKinnon; Sabin Shurraw; Ayub Akbari; Greg A Knoll; James Jaffey; Heather D Clark
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

4.  Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.

Authors:  G Roglic; H M Colhoun; L K Stevens; H H Lemkes; C Manes; J H Fuller
Journal:  Diabet Med       Date:  1998-05       Impact factor: 4.359

5.  Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study.

Authors:  Monique L Stone; Maria E Craig; Albert K Chan; Jenny W Lee; Charles F Verge; Kim C Donaghue
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

6.  Parental hypertension and proteinuria in Pima Indians with NIDDM.

Authors:  R G Nelson; D J Pettitt; M P de Courten; R L Hanson; W C Knowler; P H Bennett
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 7.  Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.

Authors:  Giuseppe Remuzzi; Manuel Macia; Piero Ruggenenti
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

8.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

9.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis.

Authors:  D K Moczulski; J J Rogus; A Antonellis; J H Warram; A S Krolewski
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

View more
  13 in total

1.  Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus.

Authors:  Roberto Hernández-Marco; Pilar Codoñer-Franch; Sara Pons Morales; Cristina Del Castillo Villaescusa; Laura Boix García; Victoria Valls Bellés
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

2.  The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood.

Authors:  Cosimo Giannini; Ebe D'Adamo; Tommaso de Giorgis; Valentina Chiavaroli; Alberto Verrotti; Francesco Chiarelli; Angelika Mohn
Journal:  Pediatr Nephrol       Date:  2011-08-26       Impact factor: 3.714

Review 3.  Nephropathy in youth and young adults with type 2 diabetes.

Authors:  Carolina Solis-Herrera; Curtis L Triplitt; Jane L Lynch
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

Review 4.  Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial.

Authors:  Jeanie B Tryggestad; Steven M Willi
Journal:  J Diabetes Complications       Date:  2014-10-29       Impact factor: 2.852

5.  Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes.

Authors:  Justin M Gregory; Guillaume Kraft; Melanie F Scott; Doss W Neal; Ben Farmer; Marta S Smith; Jon R Hastings; Eric J Allen; E Patrick Donahue; Noelia Rivera; Jason J Winnick; Dale S Edgerton; Erica Nishimura; Christian Fledelius; Christian L Brand; Alan D Cherrington
Journal:  Diabetes       Date:  2015-06-17       Impact factor: 9.461

Review 6.  Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.

Authors:  Daniel J Moore; Justin M Gregory; Yaa A Kumah-Crystal; Jill H Simmons
Journal:  Vasc Health Risk Manag       Date:  2009-11-23

7.  Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus.

Authors:  Mi Kyung Son; Ha Young Yoo; Byung Ok Kwak; Hye Won Park; Kyo Sun Kim; Sochung Chung; Hyun Wook Chae; Ho-Seong Kim; Duk Hee Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-03-31

8.  Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation.

Authors:  Xiuju Wu; Richard C Davis; Timothy S McMillen; Valerie Schaeffer; Zhiqiang Zhou; Hongxiu Qi; Parisa N Mazandarani; Roshanak Alialy; Kelly L Hudkins; Aldons J Lusis; Renée C LeBoeuf
Journal:  Physiol Rep       Date:  2014-11-26

9.  Poor Glycemic Control Can Increase the Plasma Kidney Injury Molecule-1 Concentration in Normoalbuminuric Children and Adolescents with Diabetes Mellitus.

Authors:  Moon Bae Ahn; Kyoung Soon Cho; Seul Ki Kim; Shin Hee Kim; Won Kyoung Cho; Min Ho Jung; Jin-Soon Suh; Byung-Kyu Suh
Journal:  Children (Basel)       Date:  2021-05-19

10.  Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial.

Authors: 
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.